Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimize PRO Transcatheter Aortic Valve Replacement Post Market Study

NCT04091048 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

NCT NCT04091048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04091048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimize PRO Transcatheter Aortic Valve Replacement Post Market Study
Lead sponsor
Medtronic Cardiovascular
Phase
Observational
Overall status
Completed
Start date
September 16, 2019
Completion date
November 13, 2024
Enrollment
1,127 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic aortic stenosis